
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Remove Advertising filter Advertising (2)
- Remove Australian Register of Therapeutic Goods (ARTG) filter Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (2) Apply Biologicals filter
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Remove Listed medicines filter Listed medicines (2)
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Remove Prescription medicines filter Prescription medicines (5)
- Scheduling (55) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Prescription medicines filter Prescription medicines
- (-) Remove Australian Register of Therapeutic Goods (ARTG) filter Australian Register of Therapeutic Goods (ARTG)
- (-) Remove Advertising filter Advertising
- (-) Remove Listed medicines filter Listed medicines
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
IMDRF consultation: Terminologies for categorised adverse event reporting
Closed on 12 October 2018
IMDRF consultation: Principles of labelling for medical devices and IVD medical devices
Closed on 12 September 2018
Prescription strong (Schedule 8) opioid use and misuse in Australia – options for a regulatory response
Closed on 2 March 2018
Proposed regulatory changes related to personalised and 3D printed medical devices
Closed on 22 December 2017
Alignment with European medical device regulatory framework
Closed on 25 August 2017
Comparable overseas regulators - medical devices
Closed on 30 June 2017
The Scheduling Policy Framework and Advertising of Pharmacist-only medicines (Schedule 3 substances)
Closed on 28 April 2017
Designation of Australian conformity assessment bodies for medical devices - Implementation
Closed on 11 January 2017
Accelerated assessment of medical devices - Priority Review pathway - Implementation
Closed on 11 January 2017
Software as a Medical Device (SaMD): Clinical Evaluation
Closed on 2 December 2016